Sagimet Biosciences Inc. (SGMT) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $719K. Most recent filing: Aug. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 17, 2026 filed Aug. 14, 2026 | Kemble George Director | $1,359,302 | 1,052,961 | 0% | Yes | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 11, 2026 | Kemble George Director | $72,637 | 60,618 | 0% | Yes | |
|
|
||||||
| July 22, 2026 filed July 20, 2026 | Happel David President & CEO | −$497,068 | 64,051 | −8% | No | |
|
|
||||||
| July 22, 2026 filed July 20, 2026 | Kemble George Director | −$140,529 | 18,844 | −23% | Yes | |
|
|
||||||
| July 22, 2026 filed July 20, 2026 | Rozek Elizabeth Chief Legal & Admin. Officer | −$81,832 | 10,545 | −4% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free